海南惠普森医药生物技术有限公司 China Pharma Holdings Inc. Mediaroom

China Pharma Holdings, Inc. Comments on Unusual Market Activity

HAIKOU, China, July 21, 2026 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("Ch...

2026-07-22 04:00 3077

China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity

HAIKOU, China, July 15, 2026 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("Ch...

2026-07-16 00:12 6741

China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity

HAIKOU, China, May 14, 2026 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("Chi...

2026-05-14 20:56 6365

China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split

HAIKOU, China, April 4, 2025 /PRNewswire/ -- China Pharma Holdings Inc. ("China Pharma" or the "Com...

2025-04-05 04:05 7277

China Pharma Announces the Entry of "At-The-Market" Equity Offering

HAIKOU, China, Dec. 13, 2024 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("Ch...

2024-12-13 21:00 4925

China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025

HAIKOU, China, Aug. 19, 2024 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("Ch...

2024-08-19 20:00 3883

China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split

HAIKOU, China, Feb. 23, 2024 /PRNewswire/ -- China Pharma Holdings Inc. ("China Pharma" or the "Com...

2024-02-24 05:05 6043

China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device

HAIKOU, China, Nov. 29, 2023 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("Ch...

2023-11-29 21:00 5509

China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs

HAIKOU, China, Aug. 9, 2023 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("Chi...

2023-08-09 20:30 4165

China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split

HAIKOU, China, Feb. 24, 2023 /PRNewswire/ -- China Pharma Holdings Inc. ("China Pharma" or the "Com...

2023-02-25 05:05 6365

China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask

HAIKOU, China, Dec. 28, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("Ch...

2022-12-28 21:00 3481

China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19

HAIKOU, China, Dec. 15, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("Ch...

2022-12-15 21:00 2577

Latest News

China Pharma Holdings, Inc. Comments on Unusual Market Activity

China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity

China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity

China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split

China Pharma Announces the Entry of "At-The-Market" Equity Offering

China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025

China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split

China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device

China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs

China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split

China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask

China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19

China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project

China Pharma Announces Receipt of Noncompliance Notice from NYSE American

China Pharma Announces Receipt of Notification of NYSE American Listing Deficiency

China Pharma Announced the Submission of a Plan of Compliance to NYSE American

China Pharma Announces Receipt of Noncompliance Notice from NYSE American

China Pharma Holdings, Inc. Reports Fiscal Year 2021 Financial Results

China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial Results

China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial Results